Opis działalności
Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios Manufaktur GmbH, has positioned itself in the specialty pharma segment as the go-to source for expertise and solutions. It brings together individual market players in a network of cooperating partners. Specialty pharmaceutical drugs are medications for patients with rare and/or chronic illnesses (for example, cancer, autoimmune diseases, and infectious diseases) that require lengthy and expensive treatment. Medios AG buys, sells and manages investments of innovative companies. The company aims to establish a strategic investment portfolio and to support its governance.
Zarząd & Rada nadzorcza
| CEO |
| Matthias Gärtner |
| Zarząd |
| Falk Neukirch, Christoph Prußeit, Mi-Young Miehler, Constantijn van Rietschoten |
| Rada nadzorcza |
| Dr. Yann Samson, Joachim Messner, Dr. Anke Nestler, Klaus Buß |
Dane firmy
| Nazwa: |
Medios AG |
| Adres: |
Friedrichstraße 113a,D-10117 Berlin |
| Telefon: |
+49 30 232 566 800 |
| Fax: |
+49 30 232 566 800 |
| E-mail: |
info@medios.ag
|
| Internet: |
www.medios.ag |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
58,50% |
| Data IPO: |
15.07.1999 |
Relacje inwestorskie
| Nazwa: |
Claudia Nickolaus |
| Telefon: |
+49 30 232 566 800 |
| Fax: |
- |
| E-mail: |
ir@medios.ag
|
